Login to Your Account


Antisense oligonucleotides ameliorate ataxia, ALS

By Anette Breindl
Senior Science Editor

Wednesday, April 12, 2017

Reducing expression of the protein ataxin-2 improved symptoms in mouse models of both spinocerebellar ataxia type 2 (SCA-2) and amyotrophic lateral sclerosis (ALS), scientists reported this week. Their findings appeared in two back-to-back papers in the April 13, 2017 issue of Nature.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription